Is Vancouver Canada's supervised injection facility cost-saving?

Addiction
Steven D Pinkerton

Abstract

To determine whether Vancouver's Insite supervised injection facility and syringe exchange programs are cost-saving--that is, are the savings due to averted HIV-related medical care costs sufficient to offset Insite's operating costs? The analyses examined the impact of Insite's programs for a single year. Mathematical models were used to calculate the number of additional HIV infections that would be expected if Insite were closed. The life-time HIV-related medical costs associated with these additional infections were compared to the annual operating costs of the Insite facility. If Insite were closed, the annual number of incident HIV infections among Vancouver IDU would be expected to increase from 179.3 to 262.8. These 83.5 preventable infections are associated with $17.6 million (Canadian) in life-time HIV-related medical care costs, greatly exceeding Insite's operating costs, which are approximately $3 million per year. Insite's safe injection facility and syringe exchange program substantially reduce the incidence of HIV infection within Vancouver's IDU community. The associated savings in averted HIV-related medical care costs are more than sufficient to offset Insite's operating costs.

References

Mar 1, 1990·Journal of Epidemiology and Community Health·J AshbyH Gravelle
Jun 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·T O TengsJ D Graham
Oct 1, 1995·AIDS·E H Kaplan
Jun 27, 1998·The American Journal of Drug and Alcohol Abuse·M SingerM R Weeks
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·C B McCoyS T Comerford
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R S RemisC A Hankins
Jul 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D R HoltgraveD Vlahov
Feb 3, 2004·American Journal of Infection Control·Judith Morrison, UNKNOWN Health Canada, Nosocomial and Occupational Infections Section
Sep 29, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Evan WoodMark W Tyndall
May 26, 2006·Substance Abuse Treatment, Prevention, and Policy·Evan WoodThomas Kerr
Aug 11, 2006·Harm Reduction Journal·Ernest Drucker
Nov 23, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Evan WoodThomas Kerr
Jan 1, 2008·The International Journal on Drug Policy·Andrew D Hathaway, Kirk I Tousaw
Jun 19, 2008·Lancet·Paul Webster
Nov 19, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Don C Des JarlaisHolly Hagan
Nov 19, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ahmed M Bayoumi, Gregory S Zaric
Mar 7, 2009·Harm Reduction Journal·Colin W McInnesRobert S Hogg
May 9, 2009·The International Journal on Drug Policy·Martin A Andresen, Neil Boyd

❮ Previous
Next ❯

Citations

Jan 8, 2013·The International Journal on Drug Policy·Anneli UuskülaDon C Des Jarlais
Jul 27, 2010·Addiction·Charlie Lloyd, Christine Godfrey
Jul 11, 2013·Substance Abuse Treatment, Prevention, and Policy·Ehsan JozaghiMartin A Andresen
Apr 1, 2011·The International Journal on Drug Policy·Steven D Pinkerton
Jan 6, 2012·Substance Use & Misuse·Tara Marie WatsonCarol Strike
Dec 3, 2014·Drug and Alcohol Dependence·Chloé PotierBenjamin Rolland
May 20, 2017·Harm Reduction Journal·Thomas KerrRyan McNeil
Aug 6, 2014·Substance Abuse Treatment, Prevention, and Policy·Ehsan JozaghiAlexandre Juneau
Jul 17, 2019·Addiction·Jonathan P CaulkinsBeau Kilmer
Apr 3, 2019·Drug and Alcohol Review·Vendula BelackovaMarianne Jauncey
Aug 12, 2017·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Casey LeónJessie M Gaeta
Oct 6, 2018·Hepatology, Medicine and Policy·Vendula BelackovaMarianne Jauncey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Ahmed M Bayoumi, Gregory S Zaric
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Evan WoodThomas Kerr
© 2021 Meta ULC. All rights reserved